Clinical outcomes in breast angiosarcoma patients: A rare tumor with unique challenges

Abstract

Breast AS is associated with poor survival and high recurrence rates. Prognosis may be mainly determined by its aggressive biology. Referral to tertiary care centers for multimodality treatment is recommended.